US$ 20.05
is zepbound a glp 1 drug vs glp-1 Zepbound vs. Wegovy: Comparing weight loss drugs Zepbound leads to more weight
Description
Nonetheless, to the best of our knowledge, this is the first nationwide study to evaluate the risk of developing various cancers in patients with T2DM using GLP-1 RAs compared with users of other antidiabetic drugs and non-DM control individuals over a median follow-up period of 8 years

Statements Author contributions J-YW and Q-WW wrote the first draft of the manuscript

Proactive blood pressure management is essential for patients initiating or continuing GLP-1 therapy, particularly those with risk factors for hypotension

[DOI] [PMC free article] [PubMed] [Google Scholar] 118.Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US
